Former Lab Members

Shyam wan an intern for the summer of 2023.

Mauricio was an intern in the Amgen Scholars program for the summer of 2023.

Mauricio is a current undergraduate student studying Molecular Biology and is on the pre-medicine track at Colorado College. He joined our lab in the summer of 2023 and is currently working on using single nucleus RNA-seq data from both traumatic brain injury (TBI) mimicked injury in mice and human Alzheimer diseased brains to understand the specific pathways dysregulated in TBI that contribute to Alzheimer disease etiology. Mauricio, a southern Georgia native, enjoys cooking, thrifting, and increasing diversity within the pre-health and science communities.

Brenna is a Bioinformatics Research Analyst in the lab. Since joining in 2020, her work has focused on leveraging metabolomics and single nucleus RNA sequencing data to study changes in the Alzheimer disease brain. Brenna has also developed and implemented data browsers for the lab’s multi-omic and snRNA-seq data. She received her B.S. in Genomics and Molecular Genetics from Michigan State University and her M.S. in Bioinformatics from Grand Valley State University. In her free time she enjoys crafts, cycling, and taking care of her dog and geckos.

Christopher Sohn is a Bioinformatics Research Analyst in our lab at Washington University in St. Louis. He graduated from Lehigh University with a BA in Molecular Biology and Minor in Computer Science and has a Master of Science in Bioinformatics from Johns Hopkins University.

Chris has expertise in data analysis and statistical interpretation in R and has experience in implementing bioinformatics pipelines for RNAseq data analysis.

Outside of research interests, Chris enjoys watching hockey, football, and baseball.

Yanbo is a staff scientist with a PhD in chemistry from the University of Chinese Academy of Sciences, China. During his postdoctoral training in the Department of Radiology at Washington University in St. Louis, he gained expertise in brain radiotracer development and clinical translation from bench to bedside utilizing various biochemical and statistical approaches.

With a long experience working in wet lab experiments and pharmaceutical data analysis, he joined Dr. Harari’s group in 2023. His research interests are informatics-guided biomarkers exploration and therapeutic agent discovery for central nervous system diseases.